Stocks Health care LMAT
NASDAQ · Health careLemaitre Vascular Inc (LMAT)
Lemaitre Vascular Inc brought in $262.4M of revenue over the twelve months to June 30, 2026, up 11.8% from a year earlier. Net income was $65.7M, a net margin of 25.0%. Operating cash flow minus capital spending left $74.5M of free cash flow in fiscal 2025. At June 30, 2026 it held $26.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
What Lemaitre Vascular Inc does
Lemaitre Vascular Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker LMAT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $249.6M | $57.7M | $2.52 | $74.5M |
| 2024 | $219.9M | $44M | $1.93 | $37.2M |
| 2023 | $193.5M | $30.1M | $1.34 | $29.5M |
| 2022 | $161.7M | $20.6M | $0.93 | $22.1M |
| 2021 | $154.4M | $26.9M | $1.25 | $30.2M |
| 2020 | $129.4M | $21.2M | $1.04 | $31.8M |
Latest SEC filings
What Lemaitre Vascular Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026
- August 4, 2026
- July 27, 2026Passive stake (5% or more) SCHEDULE 13G
- June 5, 2026
- May 29, 2026
- May 14, 2026Passive stake changed SCHEDULE 13G/A
- May 6, 2026Quarterly report 10-Q · period to March 31, 2026
- May 5, 2026
- April 14, 2026Additional proxy material DEFA14A
- April 14, 2026Proxy statement DEF 14A
Questions about LMAT
What does Lemaitre Vascular Inc do?
Lemaitre Vascular Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker LMAT.
Is Lemaitre Vascular Inc profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $65.7M on revenue of $262.4M, a net margin of 25.0%.
How much revenue does Lemaitre Vascular Inc make?
Over the twelve months to June 30, 2026 Lemaitre Vascular Inc reported revenue of $262.4M. That is 11.8% more than a year earlier.
When did Lemaitre Vascular Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 8, 2026.
Similar companies
Follow LMAT
Get an email when Lemaitre Vascular Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow LMAT: get an email when it filesWhere the numbers come from
Financial figures are the values Lemaitre Vascular Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.